by MM360 Staff | Jun 10, 2021 | Uncategorized
Adding Darzalex (daratumumab) to standard regimens for adults with relapsed or refractory multiple myeloma resulted in higher rates of deep and durable responses, according to exploratory analyses of two Phase 3 trials. These findings, from the ongoing POLLUX...
by MM360 Staff | Jun 10, 2021 | Uncategorized
(Washington Post) June 9, 2021 – Two members of a Food and Drug Administration advisory panel resigned this week after the agency’s contentious decision to approve an Alzheimer’s drug over the objections of its outside advisers.
by MM360 Staff | Jun 10, 2021 | Uncategorized
(ABC News) June 9, 2021 – The United States government has agreed to purchase $1.2 billion worth of an experimental COVID-19 treatment from Merck if the drug is approved by regulators, the pharmaceutical company announced Wednesday.
by MM360 Staff | Jun 10, 2021 | Uncategorized
(NCCN) June 10, 2021 – National Comprehensive Cancer Network’s patient information team provides a patient and caregiver version of recently-updated, evidence-based expert consensus recommendations for vaccinating people with cancer against COVID-19.
by MM360 Staff | Jun 10, 2021 | Uncategorized
(ABC News/Good Morning America) June 10, 2021 – A new blood test seeks to change the game in cancer management.
by MM360 Staff | Jun 10, 2021 | Uncategorized
(Evaluate Vantage) June 9, 2021 – PDS and Spectrum rise, while Black Diamond, Alpine, Harpoon and Macrogenics disappoint, and others ride on big pharma’s coattails.
